A phase II study on safety and efficacy of high-dose N-acetylcysteine in patients with cystic fibrosis.

Eur J Med Res · 2009 · PMC3352166 · PMID 19666395

Europe PMC DOI

hedged sentence

0.3000

closest p · 6.0× alpha

0.3000

boldest claim

The sentences

did not reach statistical significancep > 0.3not close (p > 0.1)

However, these differences did not reach statistical significance (p > 0.3).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.